At Mundipharma, every employee is part of a company committed to making a meaningful difference, where their work contributes to a healthier and more sustainable world. We are deeply focused on advancing Environmental, Social, and Governance (ESG) initiatives, and actively exploring how our sustainability efforts can drive positive change.
Our mission, United for Patients, extends far beyond the medicines we deliver. It reflects our responsibility to operate with integrity, to earn trust, and to create a lasting, positive impact for patients, healthcare professionals, and the communities in which we operate.
We know that credibility must be earned and our focus on ESG is part of a broader commitment to responsible growth and how we operate. Our inaugural ESG Report Sustainability Statement of Intent: Our ESG Pathway marks a significant milestone in this commitment and is the first step in sharing how we are embedding ESG principles into the core of our business. This is not supplementary, but a foundation for understanding our place in the world and how we create and deliver value.
Our pledge is to be honest about where we stand today and demonstrate meaningful progress through action.
Across our organisation, on the environmental front, we are reducing energy consumption, working to achieve zero waste to landfill, and evaluating more sustainable packaging and product constituents. From a social perspective, we are prioritising patient-centricity, supporting our people through an inclusive and empowering workplace, and strengthening our engagement with communities through our corporate social responsibility programme, Be the Difference. In terms of governance, we are enhancing leadership oversight, strengthening risk management through embedding risk considerations into decision-making and operational processes, and increasing transparency in our operations and reporting, as exemplified through this Report.
Advancing our ESG priorities requires a fundamental shift in how we think, act and lead. It demands accountability and requires Mundipharma to prioritise long-term responsibility over short-term gain. We recognise that confidence and trust in our ability to deliver will not come overnight. However, we are committed to proving ourselves through consistent and transparent action. For our partners, it is a sign that we are listening and acting. And for patients and healthcare professionals it is a commitment to act responsibly, aligned with our purpose ‘where care and collaboration meet, to make a difference when it matters most.’
As we advance our sustainability agenda with purpose and a commitment to measurable outcomes, we will strengthen data governance and broaden the scope and maturity of our ESG metrics. These insights will help to shape a comprehensive and robust ESG action plan underpinned by further reports which are scheduled as part of our annual ESG cycle.
Ultimately, our continued focus on ESG will support our strategic goals but importantly it will deliver meaningful benefits for patients, communities and society as a whole.
Marc Princen
Chief Executive Officer Mundipharma